There is some evidence that haloperidol is an effective treatment for  acute mania .
From the limited data available , there was no difference in overall efficacy of treatment between haloperidol and olanzapine or risperidone .
Some evidence suggests that haloperidol could be less effective than aripiprazole .
BACKGROUND The main objectives in treating mania are to control dangerous behaviour , reduce suicide , produce appropriate acute sedation and shorten the episode of mood disturbance .
Among different drugs , haloperidol has for many years been used in treating psychotic patients , but it has a troublesome side effect profile .
OBJECTIVES To assess the effects of haloperidol for the treatment of mania in comparison with placebo or other active drugs , either as monotherapy or add-on treatment .
Symptomatic predictors of ECT response in medication-nonresponsive manic patients.
BACKGROUND Relations between pretreatment symptom ratings and ECT outcome were examined in acute manic patients admitted at a state psychiatric center who were nonresponsive to medication . METHOD One or 2 days after undergoing pretreatment clinical ratings , patients were r and omly assigned to intensive pharmacotherapy , right unilateral ECT , left unilateral ECT , or bilateral ECT .  Patients who failed to respond to any of the first three treatment conditions were assigned to crossover bilateral ECT .  Patients who failed to respond to a primary treatment condition other than bilateral ECT but refused crossover bilateral ECT  and those in whom ECT was terminated due to an organic brain syndrome were not considered for this study . No psychotropic drugs were prescribed for 4 - 7 days before , or during , the course of ECT . Of the 24 patients who entered the study , 18 patients completed the protocol . Based on independent clinical assessment s by two research psychiatrists , a favorable treatment response was defined as a complete recovery from manic episode that was sustained for 1 week during which no psychotropic medications were prescribed . RESULTS ECT nonresponders were significantly more angry , irritable , and suspicious than ECT responders . Severity of mania and depression ratings at baseline were not related to ECT response . CONCLUSION Symptoms associated with poor response to ECT may overlap with those that have been reported to predict nonresponse to treatment with lithium . Our evidence also may support the view that differential symptom patterns may predict treatment outcomes to ECT and carbamazepine , respectively , in manic patients who do not respond to treatment with lithium or neuroleptics
There is some evidence that haloperidol is an effective treatment for  acute mania .
From the limited data available , there was no difference in overall efficacy of treatment between haloperidol and olanzapine or risperidone .
Some evidence suggests that haloperidol could be less effective than aripiprazole .
BACKGROUND The main objectives in treating mania are to control dangerous behaviour , reduce suicide , produce appropriate acute sedation and shorten the episode of mood disturbance .
Among different drugs , haloperidol has for many years been used in treating psychotic patients , but it has a troublesome side effect profile .
OBJECTIVES To assess the effects of haloperidol for the treatment of mania in comparison with placebo or other active drugs , either as monotherapy or add-on treatment .